Selection of blockbuster announcements

1、$Junshi creature (01877.HK) $Phase III clinical study of VV116 in the treatment of moderate and severe COVID-19 completes the administration of the first patient

Junshi creature announced VV116 tablets ("VV116"), an oral nucleoside anti-SARS-CoV-2 drug developed by the company's holding subsidiary Shanghai Juntuo Biopharmaceutical Technology Co., Ltd. ("Juntuo Biomedical Technology Co., Ltd.") and Suzhou Wangshan Wangshui Biomedical Co., Ltd. ("Wangshan Wangshui"), have launched an international multicenter to evaluate the efficacy and safety of standard VV116 treatment in moderate and severe COVID-19 ("COVID-19") subjects. A randomized, double-blind, controlled phase III clinical study And the first patient has been enrolled and given medicine.

2、$Bilibili Inc.-SW (09626.HK) $Will strive for voluntary conversion to dual major listing on the main board of the Hong Kong stock exchange

Bilibili Inc.-SW issued an announcement in which the board approved a motion to strive for a voluntary conversion to a dual major listing on the main board of the Hong Kong Stock Exchange. The board of directors also authorizes the senior management of the company to carry out the relevant preparatory work and proceed with the necessary formalities to complete the major listing conversion. After the major listing conversion, the company will remain a dual-listed company on the main board of the Hong Kong Stock Exchange and the NASDAQ global select market, and its Class Z common shares and American depositary shares will continue to be traded on both stock exchanges, as the case may be, and can continue to be converted to each other.

3、$China Resources Power Holdings (00836.HK) $The profit attributable to shareholders for the year 2021 is HK $1.593 billion and the proposed final dividend is HK $0.045 per share

China Resources Power Holdings released its annual results for the year ended December 31, 2021. In 2021, the group achieved a turnover of HK $89.8 billion, an increase of 29.11% over the same period last year, while the profit attributable to the company's owners was HK $1.593 billion, down 79% from the same period last year. The core profit contribution of the renewable energy business was HK $8.381 billion; basic earnings per share was HK $0.33; and the proposed final dividend was HK $0.045 per share.

4、$China Mengniu Dairy (02319.HK) $It is proposed to consider privatizing Yashili International at HK $1.2 per share and resume trading tomorrow.

Yashili International and China Mengniu Dairy jointly announced that Yashili was informed by its controlling shareholder Mengniu that Mengniu was discussing its equity and other business interests in Yashili, which may lead to a number of potential transactions, the relevant structure and details have yet to be finalized, but may include Mengniu (or through its affiliates) to make a potential conditional privatisation offer to Yashili. In addition, Yashili has applied to the Stock Exchange for the resumption of trading in Yashili shares on the Stock Exchange from 09:00 on 17 March 2022.

5、$Li Ning Co. Ltd. (02331.HK) $Clarification: the relevant statements and guesses contain false and misleading allegations about the group's operations, and do not disclose the source and reliability of the information.

Li Ning Co. Ltd. announced that recently, the company's board of directors expressed concern that the US Customs and Border Protection Bureau said in a statement that it would restrict the import of goods manufactured by the group into the United States on the grounds of the labor issues of the group's suppliers, and there are some overseas speculation about the group's suppliers. The company hopes to make the following solemn clarification with this announcement: the above statements and guesses contain false and misleading allegations about the operation of the group. And the source and reliability of the information are not disclosed, so the board of directors will not respond to every speculation or allegation.

• Financial data

The total income of Fuhong Hanlin (02696.HK) in 2021 increased by about 186.3% to 1.6825 billion yuan.

China Molybdenum's (03993) 2021 net profit increased by 119.26% to 5.106 billion yuan over the same period last year.

CK Infrastructure's annual profit attributable to shareholders in 01038 increased by 2.7% to HK $7.515 billion compared with the same period last year.

Tianhong Textile (02678) profit attributable to shareholders in 2021 increased by 419.3% to a record high of 2.69 billion yuan and a final dividend of 57 Hong Kong cents per share.

Profit attributable to shareholders of Samsonite (01910) $14.3 million in 2021

Minimally invasive Medical treatment (00853): revenue in the first two months of Xinmai Medical Technology increased by 35% year-on-year to about 187 million yuan.

Fuhong Hanlin (02696) 2021 income increased by about 186.3% to 1.6825 billion yuan compared with the same period last year.

Kingdee International Software Group (00268.HK) announced annual results: revenue exceeded 4.1 billion yuan, and cloud business revenue increased by 44.2% over the same period last year.

Jingyuan International (02232) profit attributable to owners in 2021 was US $163 million, an increase of 50.9% over the same period last year.

• Important matters

Sino Biopharmaceutical (01177): "Linezolide tablets" obtained drug registration certificate

Junshi Bio (01877): phase III clinical study of VV116 in the treatment of moderate and severe COVID-19 completes the administration of the first patient

Ganfeng Lithium (01772): Tengyuan Cobalt (301219.SZ) will be listed on Shenzhen Stock Exchange's growth Enterprise Market on March 17th.

• Tender offer

Gathering Technology (01729): the offeror completes the acquisition of 1.38 billion shares

• Repurchase cancellation

Standard Chartered PLC (02888.HK) spent 11.868 million pounds to buy back 2.5239 million shares on March 15.

HSBC Holdings PLC (00005.HK) spent 21.217 million pounds to buy back 4.435 million shares on March 15.

Ping An Healthcare And Technology (01833.HK) spent HK $8.8154 million to buy back 510000 shares on March 16.

00806.HK Group spent HK $2.4438 million to buy back 823000 shares on March 16.

00182.HK spent HK $6.9648 million to buy back 10.18 million shares on March 16.

IMAX CHINA (01970.HK) spent HK $4.5223 million to buy back 450000 shares on March 16.

00867.HK spent HK $1.4475 million to buy back 130000 shares on March 16.

• Operation data

China Resources Land (01109.HK) accumulated contract sales of about 25.07 billion yuan from January to February.

00966.HK 's original premium income in February was about 47.82 billion yuan, down 3.34% from the same period last year.

The total contract sales of Xiangsheng Holdings Group (02599.HK) belonging to the Group in the first two months was about 6.353 billion yuan.

• Investment and operation

Xuhui holding Group (00884.HK) clarified that the comments on the relevant statements were lack of rigor and seriously misled the company into having sufficient available cash reserves.

Fuhong Hanlin (02696.HK) and Shanghai Fosun Pharmaceutical Industry signed Shanghai Fosun Pharmaceutical Industrial Technical Service Agreement

With regard to the report on some food safety issues in the "March 15" evening, Riqing Foods (01475.HK) said that it had never purchased any products, including sauerkraut food, from the relevant manufacturers.

China 01618.HK: Rimu Nickel and Cobalt Project of Papua New Guinea produces nickel and cobalt hydroxide containing 5972 tons of nickel and 571tons of cobalt from January to February.

01183.HK: enter into a purchase agreement for rebar with a construction contractor in Macau

• Asset sale

Xiexin New Energy (00451) subsidiary plans to sell seven operating photovoltaic plants for 90.3798 million yuan, which will reduce the debt by about 354 million yuan.

• Delisting and delisting

Jingxi International (02788): privatization will be delisted on March 18.